Edmond de Rothschild Holding’s Quest Diagnostics DGX Stock Holding History

Edmond de Rothschild Holding’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$944K	Buy	4,452 +270	+6%	+$53K	0.01%	311
2026 Q1	$820K	Buy	4,182 +1,446	+53%	+$281K	0.01%	302
2025 Q4	$475K	Buy	2,736 +1,974	+259%	+$359K	0.01%	331
2025 Q3	$145K	Buy	762 +312	+69%	+$55.4K	﹤0.01%	409
2025 Q2	$80.8K	Hold	450	–	–	﹤0.01%	425
2025 Q1	$76.1K	Buy	+450	New	+$73.9K	﹤0.01%	432
2023 Q3	–	Sell	-31,034	Closed	-$4.36M	–	717
2023 Q2	$4.36M	Buy	+31,034	New	+$4.28M	0.09%	186
2020 Q4	–	Sell	-118	Closed	-$14K	–	650
2020 Q3	$14K	Hold	118	–	–	﹤0.01%	579
2020 Q2	$13K	Buy	+118	New	+$12.5K	﹤0.01%	566
2019 Q4	–	Sell	-8,300	Closed	-$888K	–	588
2019 Q3	$888K	Buy	8,300 +1,100	+15%	+$113K	0.04%	255
2019 Q2	$733K	Hold	7,200	–	–	0.03%	263
2019 Q1	$647K	Hold	7,200	–	–	0.02%	268
2018 Q4	$600K	Hold	7,200	–	–	0.02%	294
2018 Q3	$777K	Hold	7,200	–	–	0.02%	300
2018 Q2	$792K	Hold	7,200	–	–	0.02%	295
2018 Q1	$722K	Hold	7,200	–	–	0.02%	311
2017 Q4	$709K	Hold	7,200	–	–	0.02%	314
2017 Q3	$674K	Hold	7,200	–	–	0.02%	326
2017 Q2	$800K	Hold	7,200	–	–	0.02%	315
2017 Q1	$707K	Hold	7,200	–	–	0.02%	330
2016 Q4	$662K	Hold	7,200	–	–	0.02%	331
2016 Q3	$609K	Hold	7,200	–	–	0.02%	341
2016 Q2	$586K	Hold	7,200	–	–	0.02%	340
2016 Q1	$514K	Hold	7,200	–	–	0.02%	356
2015 Q4	$512K	Hold	7,200	–	–	0.01%	359
2015 Q3	$443K	Sell	7,200 -910	-11%	-$63.6K	0.01%	361
2015 Q2	$588K	Buy	+8,110	New	+$599K	0.01%	358

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Edmond de Rothschild Holding's DGX Position: Q2 2026 in Review

Edmond de Rothschild Holding increased its Quest Diagnostics (DGX) stake by 6.5% in Q2 2026, buying an estimated $53K and bringing the position to 4,452 shares worth $944K. The position accounts for 0.01% of the portfolio, ranked #311.

Edmond de Rothschild Holding first reported a position in DGX in Q2 2015 and has held it in 27 quarters since. The position peaked at $4.36M in Q2 2023. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Edmond de Rothschild Holding held 4,452 shares of Quest Diagnostics worth $944K as of Q2 2026.
Edmond de Rothschild Holding bought 270 Quest Diagnostics shares in Q2 2026, an estimated $53K.
Quest Diagnostics made up 0.01% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #311 holding.
Edmond de Rothschild Holding first reported a position in Quest Diagnostics in Q2 2015 and has held it in 27 quarters since.
Edmond de Rothschild Holding's Quest Diagnostics position peaked at $4.36M in Q2 2023.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.